Semler Scientific (NASDAQ:SMLR) Releases Earnings Results, Beats Expectations By $0.35 EPS

Semler Scientific (NASDAQ:SMLR) posted its earnings results on Monday. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35, Zacks reports. Semler Scientific had a net margin of 27.00% and a return on equity of 20.93%. The firm had revenue of $13.51 million during the quarter.

Semler Scientific Price Performance

SMLR stock traded down $1.98 on Thursday, reaching $38.13. The company’s stock had a trading volume of 188,426 shares, compared to its average volume of 192,246. The firm has a fifty day moving average of $26.37 and a two-hundred day moving average of $28.81. The company has a market capitalization of $266.60 million, a P/E ratio of 19.57 and a beta of 0.92. Semler Scientific has a 52 week low of $20.88 and a 52 week high of $53.38.

Insider Activity

In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total value of $283,500.00. Following the completion of the sale, the chief executive officer now directly owns 60,220 shares of the company’s stock, valued at approximately $1,707,237. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 30.20% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.